| Abstract | Five patients who had Felty's syndrome were treated with auranofin, 6 mg/day, for a period that ranged from 4 months to 2 years. All patients experienced both an improvement in articular symptoms and a normalization of the leukocyte count. Auranofin appears to be an effective treatment for Felty's syndrome, and to have a lower degree of toxicity than parenteral gold. |
| Authors | A Bellelli, M Veneziani, B Tumiati
(Affiliation: Second Department of Medicine, S. Maria Nuova Hospital, Reggio Emilia, Italy.)
|
| Journal | Arthritis and rheumatism
(Arthritis Rheum)
Vol. 30
Issue 9
Pg. 1057-61
(Sep 1987)
ISSN: 0004-3591 UNITED STATES |
| PMID | 3663254
(Publication Type: Journal Article)
|
| Chemical References |
|
| Topics |
- Aged
- Auranofin
(adverse effects, therapeutic use)
- Chronic Disease
- Drug Evaluation
- Felty's Syndrome
(drug therapy)
- Female
- Follow-Up Studies
- Humans
- Leukocyte Count
(drug effects)
- Middle Aged
- Time Factors
|
